MIM
CTIC

MetLife Investment Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

MetLife Investment Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-48,688
Closed -$204K – 3036
2023
Q1 		$204K Hold
48,688
– – ﹤0.01% 2210
2022
Q4 		$293K Hold
48,688
– – ﹤0.01% 2006
2022
Q3 		$283K Hold
48,688
– – ﹤0.01% 2062
2022
Q2 		$291K Buy
+48,688
New +$249K ﹤0.01% 2044
2018
Q3 		– Sell
-27,473
Closed -$137K – 2675
2018
Q2 		$137K Buy
+27,473
New +$120K ﹤0.01% 2103

Other funds holding CTIC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return